Chronic kidney disease (CKD) patients are characterized by a high residual risk for
cardiovascular (CV) events and CKD progression. This has prompted the implementation of …

Globally, chronic kidney disease (CKD) contributes substantial morbidity and mortality.
Recently, various 'omics platforms have provided insight into the molecular basis of kidney …

Patients with chronic kidney disease (CKD) are at increased risk of atherosclerosis and
premature mortality, mainly due to cardiovascular events. However, well-known risk factors …

Chronic kidney disease (CKD), defined as the presence of albuminuria and/or reduction in
estimated glomerular filtration rate (eGFR)< 60 mL/min/1.73 m2, is considered a growing …

The quest for the ideal therapeutic target in chronic kidney disease (CKD) has been riddled
with many obstacles stemming from the molecular complexity of the disease and its co …

Chronic kidney diseases (CKDs) are currently classified according to their clinical features,
associated comorbidities and pattern of injury on biopsy. Even within a given classification …

Chronic Kidney Disease (CKD) constitutes a global health crisis, silently affecting millions
worldwide. This condition, characterized by a gradual decline in kidney function, places a …

The prevalence of chronic kidney disease (CKD) is increasing worldwide, and the mortality
rate continues to be unacceptably high. The biomarkers currently used in clinical practice …

In its early stages, symptoms of chronic kidney disease (CKD) are usually not apparent.
Significant reduction of the kidney function is the first obvious sign of disease. If diagnosed …

Chronic kidney disease (CKD) is an epidemic health issue that requires global attention [1].
The worldwide increment of CKD incidence is related to an increase in traditional risk factors …